Differential Roles of the mTOR-STAT3 Signaling in Dermal γδ T Cell Effector Function in Skin Inflammation

Area of Science:

• Immunology
• Dermatology
• Molecular Biology

Background:

• Dermal γδT cells are crucial for skin homeostasis and inflammation.
• The precise molecular triggers for dermal γδT cell activation remain incompletely understood.

Purpose of the Study:

• To elucidate the molecular mechanisms governing dermal γδT cell activation and function in skin inflammation.
• To investigate the roles of mechanistic or mammalian target of rapamycin (mTOR) and STAT3 signaling pathways.

Main Methods:

• Activation of dermal γδT cells using innate stimuli like interleukin-1β (IL-1β) and IL-23.
• Analysis of mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) roles in cell proliferation.
• Assessment of STAT3 pathway involvement in effector functions and IRF-4 activation.

Main Results:

• mTOR and STAT3 pathways are activated in dermal γδT cells by IL-1β and IL-23.
• mTORC1 and mTORC2 are vital for proliferation; mTORC2 specifically impacts dermal γδT17 cells, linked to oxidative phosphorylation.
• STAT3 is essential for Vγ4T17 effector function but not Vγ6T17 cells; IRF-4 links IL-1β/IL-23 signaling to IL-17 production.
• Absence of mTORC2, but not STAT3, in dermal γδT cells reduces skin inflammation.

Conclusions:

• mTOR-STAT3 signaling differentially controls dermal γδT cell effector functions in skin inflammation.
• mTORC2 plays a key role in regulating dermal γδT17 cell populations and skin inflammation severity.
• Targeting mTOR-STAT3 pathways may offer therapeutic strategies for inflammatory skin conditions.